| | 59435 | | 03.02.2010 | | Labatec Pharma SA | | | | | | | | | | | | 01.09. | | | | 01.09. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Ondansetron Labatec, 4mg/2ml | concentré pour perfusion | Concentrate for infusion (Ondansetron 4mg / 2ml) | A04AA01 | | 02 | Ondansetron Labatec, 8mg/4ml | concentré pour perfusion | Concentrate for infusion (Ondansetron 8mg / 4ml) | A04AA01 | |
|
|